Climb Bio, Inc. Share Price
NASDAQ: CLYM | Small CapClimb Bio, Inc. Stock Performance
Climb Bio, Inc. Share Price Today
As of 29 October 2026, Climb Bio, Inc.'s share price is $10.48. The stock opened at $10.36, compared to its previous close of $10.13. During today's trading session, Climb Bio, Inc.'s share price traded between $10.10 and $10.52, with an average price of $10.31. Over the past 52 weeks, the stock has recorded a high of $18.32 and a low of $1.64. In terms of performance, Climb Bio, Inc.'s share price has risen by 18.15% over the last six months and is up 413.73% on a year-on-year basis.
Climb Bio, Inc. Share Price Chart
Climb Bio, Inc. Quarterly Profit & Loss
All figures in USD
Climb Bio, Inc. Annual Profit & Loss
All figures in USD
About Climb Bio, Inc.
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
Climb Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $11.38 | $10.46 | -9.12% |
Sep 2026 | $13.29 | $11.51 | -23.60% |
Aug 2026 | $11.67 | $15.06 | +26.54% |
Jul 2026 | $12.98 | $11.90 | -8.77% |
Jun 2026 | $10.94 | $13.05 | +19.18% |
May 2026 | $8.61 | $10.95 | +23.45% |
Apr 2026 | $7.10 | $8.87 | +29.49% |
Mar 2026 | $6.79 | $6.85 | -4.60% |
Feb 2026 | $4.50 | $7.18 | +60.63% |
Jan 2026 | $4.10 | $4.47 | +11.75% |
Dec 2025 | $1.86 | $4.00 | +112.77% |
Nov 2025 | $2.06 | $1.88 | -7.84% |